ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2024

Mar 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2024-02-29

Reporting Person: Wilson Martin (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-29	Common Stock	S	4100	$29.331	Disposed	18680	Direct

Footnotes

F1: Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.33 to $29.37. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.